<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Song T</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><pagination>5894-5900</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10965196</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>146(9)</volume><pubmed_abstract>Coronavirus transmission and mutations have brought intensive challenges on pandemic control and disease treatment. Developing robust and versatile antiviral drugs for viral neutralization is highly desired. Here, we created a new polyvalent nanobody (Nb) structure that shows the effective inhibition of SARS-CoV-2 infections. Our polyvalent Nb structure, called "PNS", is achieved by first conjugating single-stranded DNA (ssDNA) and the receptor-binding domain (RBD)-targeting Nb with retained binding ability to SARS-CoV-2 spike protein and then coalescing the ssDNA-Nb conjugates around a gold nanoparticle (AuNP) via DNA hybridization with a desired Nb density that offers spatial pattern-matching with that of the Nb binding sites on the trimeric spike. The surface plasmon resonance (SPR) ass</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition.</pubmed_title><pmcid>PMC10965196</pmcid><funding_grant_id>R01 AI159454</funding_grant_id><funding_grant_id>R21AI166898</funding_grant_id><funding_grant_id>R21 AI166898</funding_grant_id><funding_grant_id>R01AI159454</funding_grant_id><pubmed_authors>Cooper L</pubmed_authors><pubmed_authors>Song T</pubmed_authors><pubmed_authors>Dwivedy A</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Galvan Achi J</pubmed_authors><pubmed_authors>Rong L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition.</name><description>Coronavirus transmission and mutations have brought intensive challenges on pandemic control and disease treatment. Developing robust and versatile antiviral drugs for viral neutralization is highly desired. Here, we created a new polyvalent nanobody (Nb) structure that shows the effective inhibition of SARS-CoV-2 infections. Our polyvalent Nb structure, called "PNS", is achieved by first conjugating single-stranded DNA (ssDNA) and the receptor-binding domain (RBD)-targeting Nb with retained binding ability to SARS-CoV-2 spike protein and then coalescing the ssDNA-Nb conjugates around a gold nanoparticle (AuNP) via DNA hybridization with a desired Nb density that offers spatial pattern-matching with that of the Nb binding sites on the trimeric spike. The surface plasmon resonance (SPR) ass</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-18T21:20:25.45Z</modification><creation>2025-04-07T09:17:08.602Z</creation></dates><accession>S-EPMC10965196</accession><cross_references><pubmed>38408177</pubmed><doi>10.1021/jacs.3c11760</doi></cross_references></HashMap>